PALO ALTO, Calif., Jan. 30, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced that it will webcast a conference callto discuss the details of the agreement, also announced today, to acquire all the outstanding shares of Sirtex Medical Limited (ASX: SRX) ("Sirtex"). Sirtex is an Australia-based global life sciences company focused
The conference call and webcast will start at 9:00 a.m. ET on Tuesday, January 30, 2018. To access the teleconference call and replay:
Teleconference: Access from within the U.S. by dialing 1-877-869-3847, and from outside the U.S. by dialing 1-201-689-8261.
Webcast: The live webcast and replay will be available on the Varian Investor Relations website at www.varian.com/investors.
Varian is a leader in developing and delivering cancer care solutions, and is focused on creating a world without fear of cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,500 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
Investor Relations Contact
J. Michael BruffVice President, Investor Relations+1 (650) email@example.com
Mark PlungyDirector, Public Relations+1 (650) firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/varian-to-discuss-agreement-to-acquire-sirtex-300590021.html
Subscribe to our Free Newsletters!
Dental Anxiety is kind of dental phobia where a person has a fear of going to dentist mainly due to ...
Kleine Levin (KLS) or sleeping beauty syndrome is a rare neurological disorder that primarly ...
LADA or Latent Autoimmune Diabetes of Adulthood is a form of type 1 autoimmune diabetes that can be ...View All